EVGN:NASDAQ
Evogene Ltd
$0,42
arrow_downward
-3,08%(-0,014) 1G
$0,39
arrow_downward
-7,72% (-0,033)bedtimeKapanış sonrası
Kapandı: 7 Tem, 16:00:01 GMT-4 · USD
search
Tüm semboller
1G
5G
1A
6A
Yıl Başından Beri
1Y
5Y
MAKS
| Sembol | Fiyat | Değişiklik | Değişiklik % |
|---|
insights_autoEVGN ile ilgili en önemli analizler oluşturuluyor...
Açık
$0,43
Yüksek
$0,44
Düşük
$0,41
Piy. değ.
3,69 Mn
Ort. hacim
2,20 Mn
İşlem Hacmi
193,00
52 haftalık en yüksek
$1,50
52 haftalık en düşük
$0,37
HBK
-$1,38
Beta
1,40
Tedavüldeki hisse senedi sayısı
12,10 Mn
Çalışan sayısı
52
Açık
$0,43
Yüksek
$0,44
Düşük
$0,41
Piy. değ.
3,69 Mn
Ort. hacim
2,20 Mn
İşlem Hacmi
193,00
52 haftalık en yüksek
$1,50
52 haftalık en düşük
$0,37
HBK
-$1,38
Beta
1,40
Tedavüldeki hisse senedi sayısı
12,10 Mn
Çalışan sayısı
52
Haberler
Web genelindeki kaynaklardan
Simply Wall Street
·
1 dakika önce
The Bull Case For Impinj (PI) Could Change Following Its Upcoming Q2 Results And Q3 Outlook
Trefis
·
50 dakika önce
Where The Buying Ran Strongest: 26 Large Cap Stocks At 52-Week Highs
Yahoo Finance
·
1 saat önce
3 of the Top 5 Performers in the S&P 500 in the First Half Offer 1 Particular Thing for AI Customers. (Hint: It Isn't the GPU, and Nvidia Isn't Among Them.)
WSJ
·
12 saat önce
SpaceX Shares Stumble in Nasdaq-100 Debut
Profil
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Evogene Ltd hakkında
Yapay zeka içeriklerinde hata olabilir. Daha fazla bilgi